Skip to main content

MoneyWorks4Me

Acutaas Chemicals - Quaterly Results

28 Oct 2026 Evaluate
The sales surged to Rs. 4330.48 millions, up 41.89% for the September 2026 quarter as against Rs. 3051.93 millions during the corresponding quarter previous year.Profit for the quarter ended September 2026 rises by 86.22% to Rs. 1357.36  millions from Rs. 728.91 millions.Operating Profit saw a handsome growth to 1913.87 millions from 1055.75 millions in the quarter ended September 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 4330.48 3051.93 41.89 7554.57 5111.64 47.79 13237.92 9898.35 33.74
Other Income 80.46 89.70 -10.30 125.22 249.90 -49.89 458.78 183.36 150.21
PBIDT 1913.87 1055.75 81.28 3055.40 1725.84 77.04 5288.83 2434.78 117.22
Interest 9.94 5.72 73.78 21.12 11.92 77.18 30.77 58.57 -47.46
PBDT 1903.93 1050.03 81.32 3034.28 1713.92 77.04 5258.06 2376.21 121.28
Depreciation 93.13 77.22 20.60 183.33 151.84 20.74 330.32 240.45 37.38
PBT 1810.80 972.81 86.14 2850.95 1562.08 82.51 4927.74 2135.76 130.73
TAX 453.44 243.90 85.91 734.63 386.71 89.97 1265.99 540.29 134.32
Deferred Tax 61.19 50.38 21.46 87.06 65.91 32.09 111.09 70.58 57.40
PAT 1357.36 728.91 86.22 2116.32 1175.37 80.06 3661.75 1595.47 129.51
Equity 409.36 409.36 0.00 409.36 409.36 0.00 409.36 409.34 0.00
PBIDTM(%) 44.20 34.59 27.76 40.44 33.76 19.79 39.95 24.60 62.42
Peers
Company Name CMP
Sun Pharma. Inds. 1758.00
Dr. Reddys Labs. 1335.40
Cipla 1360.00
Lupin 1971.00
Zydus Lifesciences 1172.00
View more..